Brief: Anika Therapeutics Q2 Adjusted Loss Per Share $0.12

Anika Therapeutics

03/08/2022 22:46

Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULTS
    * Q2 ADJUSTED LOSS PER SHARE $0.12
    * Q2 LOSS PER SHARE $0.20
    * REVENUE IN Q2 OF 2022 WAS $39.7 MILLION, UP 4%

Source text for Eikon:  ID:nGNX3FdNfQ 
Further company coverage:  ANIK.O